(Reuters) - The U.S. Justice Department said on Wednesday it had filed a false claims act complaint against Regeneron Pharmaceuticals, claiming the company filed false average sales price reports. The complaint, filed under the U.S. False Claims Ac.
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
US Justice Department Files Complaint Against Regeneron, Alleges Fraudulent Drug Pricing usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.
US Justice department files complaint against Regeneron, alleges fraudulent drug pricing yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.